| Image |
No pdb structure |
| GO Annotations |
Cellular Component |
|
| Molecular Function |
|
| Biological Process |
|
| Pathways |
|
| Drugs |
|
| Diseases |
|
| GWAS |
- Albumin-globulin ratio ( 29403010)
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Asthma ( 31619474)
- Asthma (adult onset) ( 31036433)
- Bipolar disorder ( 28115744 31043756)
- Bipolar I disorder ( 31043756)
- C-reactive protein levels or LDL-cholesterol levels (pleiotropy) ( 27286809)
- Change in serum metabolite levels ( 31636271)
- Change in serum metabolite levels (CMS) ( 31636271)
- Cholesterol, total ( 24097068 19060911 25961943 20686565)
- Cholesteryl ester levels ( 31551469)
- Colorectal cancer ( 24836286)
- Comprehensive strength and appendicular lean mass ( 22960237)
- Crohn's disease ( 28067908)
- Delta-5 desaturase activity response to n3-polyunsaturated fat supplement ( 29246731)
- Fatty acid desaturase activity (serum) ( 30453627)
- Gallstone disease ( 30504769)
- Glycated hemoglobin levels ( 24647736 28898252)
- Glycerophospholipid levels ( 26068415)
- Gondoic acid (20:1n-9) levels ( 28298293)
- Granulocyte count ( 27863252)
- Granulocyte percentage of myeloid white cells ( 27863252)
- HDL cholesterol ( 24097068 19060906 19060911 25961943 20686565)
- HDL cholesterol levels ( 28334899 30698716)
- HDL cholesterol levels in current drinkers ( 30698716)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Heel bone mineral density ( 28869591)
- Height ( 31562340)
- Hemoglobin A1c levels ( 29403010)
- IgA levels ( 28628107)
- Inflammatory bowel disease ( 23128233)
- Iron status biomarkers (transferrin levels) ( 25352340)
- Laryngeal squamous cell carcinoma ( 25194280)
- LDL cholesterol ( 24097068 19060910 19060911 25961943 20686565)
- LDL cholesterol levels ( 28334899 30698716)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x long total sleep time interaction (2df test) ( 31719535)
- LDL cholesterol levels x short total sleep time interaction (2df test) ( 31719535)
- Lipid metabolism phenotypes ( 22286219)
- Liver enzyme levels (alkaline phosphatase) ( 22001757)
- Lung cancer in ever smokers ( 28604730)
- Lysophosphatidylcholine levels ( 31551469)
- Lysophosphatidylethanolamine levels ( 31551469)
- Male-pattern baldness ( 28196072)
- Mean platelet volume ( 27863252)
- Medication use (adrenergics, inhalants) ( 31015401)
- Medication use (thyroid preparations) ( 31015401)
- Metabolic syndrome ( 20694148 31589552)
- Metabolite levels ( 23823483 23378610 22916037)
- Metabolite levels (lipid measures) ( 27005778)
- Metabolite risk score for predicting weight gain ( 31560688)
- Moyamoya disease ( 29273593)
- Myeloid white cell count ( 27863252)
- Neutrophil count ( 27863252)
- Non-albumin protein levels ( 29403010)
- Oleic acid (18:1n-9) levels ( 28298293 23362303)
- P wave duration ( 24850809)
- Palmitoleic acid (16:1n-7) levels ( 28298293 23362303)
- Phosphatidylcholine levels ( 31551469)
- Phosphatidylcholine-ether levels ( 31551469)
- Phosphatidylethanolamine levels ( 31551469)
- Phosphatidylethanolamine-ether levels ( 31551469)
- Phosphatidylinositol levels ( 31551469)
- Phospholipid levels (plasma) ( 22359512)
- Plasma omega-3 polyunsaturated fatty acid level (eicosapentaenoic acid) ( 21829377)
- Plasma omega-3 polyunsaturated fatty acid levels (alphalinolenic acid) ( 21829377)
- Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid) ( 21829377)
- Plasma omega-6 polyunsaturated fatty acid levels (adrenic acid) ( 24823311)
- Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid) ( 24823311)
- Plasma omega-6 polyunsaturated fatty acid levels (dihomo-gamma-linolenic acid) ( 24823311)
- Plasma omega-6 polyunsaturated fatty acid levels (gamma-linolenic acid) ( 24823311)
- Plasma omega-6 polyunsaturated fatty acid levels (linoleic acid) ( 24823311)
- Platelet count ( 29403010)
- Plateletcrit ( 27863252)
- Pulse pressure ( 30578418)
- QRS duration ( 27659466)
- QT interval ( 24952745)
- Red blood cell fatty acid levels ( 25500335)
- Red cell distribution width ( 27863252)
- Response to statin therapy ( 20339536)
- Resting heart rate ( 29769521 27798624)
- Rheumatoid arthritis ( 30423114 24390342)
- Serum metabolite concentrations in chronic kidney disease ( 29545352)
- Serum metabolite levels ( 31636271 23093944)
- Serum metabolite levels (CMS) ( 31636271)
- Serum metabolite ratios in chronic kidney disease ( 29545352)
- Sphingolipid levels ( 26068415 22359512)
- Sphingomyelin levels ( 31551469)
- Stearic acid (18:0) levels ( 23362303)
- Sum basophil neutrophil counts ( 27863252)
- Sum neutrophil eosinophil counts ( 27863252)
- Total cholesterol levels ( 28334899 29403010)
- Triacylglyceride levels ( 31551469)
- Triacylglycerol 56:6 levels ( 31560688)
- Triglyceride levels ( 28334899 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Triglycerides ( 24097068 19060906 25961943 20686565)
- Urate levels ( 31578528)
- Vaccenic acid (18:1n-7) levels ( 28298293)
- Vitiligo ( 27723757)
|
| Interacting Genes |
1 interacting genes:
ATXN1L
|
| Entrez ID |
9415 |
| HPRD ID |
05854 |
| Ensembl ID |
ENSG00000134824
|
| Uniprot IDs |
O95864
|
| PDB IDs |
|
| Enriched GO Terms of Interacting Partners? |
|
| Tagcloud ? |
|